Dr. Haass graduated in Molecular Biology at the University of Heidelberg, Germany. He was a postdoc and assistant professor of Neurology at the Harvard Medical School in the institute of Dr. Dennis Selkoe. He was appointed as professor at the Central Institute of Mental Health in Mannheim in 1995. Since 1999 he is the head of the division of Biochemistry at the Ludwig-Maximilians-University and since 2009 he is also the speaker of the German Center for Neurodegenerative Diseases (DZNE) in Munich. Since 2012, he is speaker of the DFG Excellence Cluster "Systems Neurology" (SyNergy). Dr. Haass was member of the senate of the Deutsche Forschungsgemeinschaft (DFG) and he is elected member of the European Molecular Biology Organization (EMBO), the Leopoldina and the Bavarian Academy of Sciences and Humanities. He has received a number of prestigious awards, among them the Gottfried Wilhelm Leibniz-Award of the Deutsche Forschungsgemeinschaft, the Potamkin Award of the American Academy of Neurology, the ERC advanced grant, a Honorary Degree of the University of Zurich, the Order of Merrit on Ribbon from the Federal Republic of Germany, the MetLife Foundation Award for Medical Research and the Brain Prize.

After I obtained my doctoral degree in Neurobiology at the University of Freiburg, Germany, I joined the research group of Daniel Ferreira at Karolinska Institutet as a postdoctoral researcher in May 2021. In my work at Karolinska Institutet, I use cognitive and multimodal imaging data from large international cohorts to investigate healthy and pathological ageing, with a special focus on dementia with Lewy bodies. My special interest are network in a variety of modalities.

I am an Assistant Professor in Neurology at Brigham and Women's Hospital and Harvard Medical School in Boston, USA. Come April 2024, I will join the Medical University of Vienna as an Assistant Professor and independent group leader at the Max Perutz Labs in Austria. My training at prestigious institutions like Heidelberg University, EMBL, Max Planck Institutes and MIT's Whitehead Institute has immersed me in the breadth of scientific thought, emphasizing the synergy between basic and applied research. My work ranges from transcription regulation to the molecular mechanisms of Parkinson's Disease, employing techniques across models from bacteria to human neurons. This journey has honed my skill in discerning critical biological inquiries and fostered a dedication to collaborative, innovative problem-solving. Currently, I am focused on unraveling the complexities of synucleinopathies, advocating for novel, cross-disciplinary strategies to advance our understanding and treatment of Parkinson's Disease. As a motivated junior investigator, I am poised to confront this disease with a rich background in diverse scientific disciplines.